1. Allende, Gonzalo, Chávez-Reyes, Jesús, Guerrero-Alba, Raquel, Vázquez-León, Priscila, Marichal-Cancino, Bruno A. 2020. Advances in Neurobiology and Pharmacology of GPR12. In Frontiers in pharmacology, 11, 628. doi:10.3389/fphar.2020.00628. https://pubmed.ncbi.nlm.nih.gov/32457622/
2. Wang, Lu, Yang, Da, Zhang, Yao, Jiao, Yisheng. 2022. GPR12 Inhibits Apoptosis in Epithelial Ovarian Cancer via the Activation of ERK1/2 Signaling. In Frontiers in oncology, 12, 932689. doi:10.3389/fonc.2022.932689. https://pubmed.ncbi.nlm.nih.gov/35903681/
3. Zhang, Minfa, Yang, Xiaoqi, Chen, Shuai, Liu, Heng, Pan, Xinliang. 2021. GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells. In Thoracic cancer, 12, 1525-1535. doi:10.1111/1759-7714.13933. https://pubmed.ncbi.nlm.nih.gov/33742771/
4. Morales, Paula, Isawi, Israa, Reggio, Patricia H. 2018. Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12. In Drug metabolism reviews, 50, 74-93. doi:10.1080/03602532.2018.1428616. https://pubmed.ncbi.nlm.nih.gov/29390908/
5. Brown, Kevin J, Laun, Alyssa S, Song, Zhao-Hui. 2017. Cannabidiol, a novel inverse agonist for GPR12. In Biochemical and biophysical research communications, 493, 451-454. doi:10.1016/j.bbrc.2017.09.001. https://pubmed.ncbi.nlm.nih.gov/28888984/